How much is an Ogen stock worth?
One share of OGEN stock can currently be purchased for approximately $0.34. How much money does Oragenics make? Oragenics has a market capitalization of $39.59 million. The biotechnology company earns $-26.43 million in net income (profit) each year or ($0.17) on an earnings per share basis.
Who bought oogen stock?
OGEN stock was sold by a variety of institutional investors in the last quarter, including Virtu Financial LLC. View insider buying and selling activity for Oragenics or view top insider-selling stocks. Which major investors are buying Oragenics stock?
Are Oragenics insiders buying or selling stock?
In the past three months, Oragenics insiders have not sold or bought any company stock. Only 5.30% of the stock of Oragenics is held by insiders. Only 9.23% of the stock of Oragenics is held by institutions.
Will Ogen outperform or underperform the S&P 500 over the long term?
MarketBeat's community ratings are surveys of what our community members think about Oragenics and other stocks. Vote “Outperform” if you believe OGEN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe OGEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
Should I invest in Oragenics?
Is Oragenics Inc stock A Buy? Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.
Who owns Ogen stock?
Top 10 Owners of Oragenics IncStockholderStakeShares ownedThe Vanguard Group, Inc.4.31%5,017,144Sara-Bay Financial Corp.1.73%2,008,117BlackRock Fund Advisors1.13%1,315,396Geode Capital Management LLC0.63%731,3046 more rows
How has Oragenics' stock performed in 2022?
Oragenics' stock was trading at $0.5237 at the start of the year. Since then, OGEN shares have decreased by 37.0% and is now trading at $0.33. Vie...
Are investors shorting Oragenics?
Oragenics saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 2,080,000 shares, a drop of 32.2%...
How were Oragenics' earnings last quarter?
Oragenics, Inc. (NYSEAMERICAN:OGEN) issued its quarterly earnings results on Friday, May, 13th. The biotechnology company reported ($0.05) earnings...
When did Oragenics' stock split? How did Oragenics' stock split work?
Oragenics shares reverse split on Monday, January 22nd 2018. The 1-10 reverse split was announced on Monday, January 8th 2018. The number of shares...
Who are Oragenics' key executives?
Oragenics' management team includes the following people: Dr. Frederick W. Telling Ph.D. , Exec. Chairman (Age 70, Pay $213.85k) Mr. Michael O....
Who are some of Oragenics' key competitors?
Some companies that are related to Oragenics include OptiNose (OPTN) , Nanobiotix (NBTX) , Werewolf Therapeutics (HOWL) , Longeveron (LGVN) ,...
What other stocks do shareholders of Oragenics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Oragenics investors own include Celsion (CLSN) , Jaguar H...
What is Oragenics' stock symbol?
Oragenics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "OGEN."
Who are Oragenics' major shareholders?
Oragenics' stock is owned by many different institutional and retail investors. Top institutional investors include State Street Corp (0.43%) and R...
How has Oragenics' stock price performed in 2022?
Oragenics' stock was trading at $0.4240 at the start of the year. Since then, OGEN stock has decreased by 22.2% and is now trading at $0.33. View...
How were Oragenics' earnings last quarter?
Oragenics, Inc. (NYSE:OGEN) released its quarterly earnings data on Thursday, March, 24th. The company reported ($0.02) earnings per share for the...
Who are Oragenics' key executives?
Oragenics' management team includes the following people: Dr. Frederick W. Telling Ph.D. , Exec. Chairman (Age 70, Pay $213.85k) Mr. Michael O....
Who are some of Oragenics' key competitors?
Some companies that are related to Oragenics include OptiNose (OPTN) , Nanobiotix (NBTX) , Werewolf Therapeutics (HOWL) , Longeveron (LGVN) ,...
What other stocks do shareholders of Oragenics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Oragenics investors own include Yunji (YJ) , InspireMD (N...
What is Oragenics' stock symbol?
Oragenics trades on the New York Stock Exchange (NYSE) under the ticker symbol "OGEN."
How do I buy shares of Oragenics?
Shares of OGEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
What is Oragenics' stock price today?
One share of OGEN stock can currently be purchased for approximately $0.33.
How much money does Oragenics make?
Oragenics (NYSE:OGEN) has a market capitalization of $38.41 million and generates $90 thousand in revenue each year. The company earns $-15.71 mill...
Stock Price Forecast
Analyst Recommendations
The 1 analysts offering 12-month price forecasts for Oragenics Inc have a median target of 2.50, with a high estimate of 2.50 and a low estimate of 2.50. The median estimate represents a +649.63% increase from the last price of 0.33.
Signals & Forecast
The current consensus among 1 polled investment analysts is to Buy stock in Oragenics Inc. This rating has held steady since August, when it was unchanged from a Buy rating. Move your mouse over past months for detail
Support, Risk & Stop-loss
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Oragenics Inc stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock.
Is Oragenics Inc stock A Buy?
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
Insiders are negative as most recent trades are sells in Oragenics Inc
Oragenics Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Golden Star Signal
In the last 100 trades there were 22.01 million shares bought and 9.95 million shares sold. The last trade was done 51 days ago by Koski Robert C who bough 799.1 thousand shares. For the period there has been more stocks bought than sold among the insiders, but most of the latest transaction have been insiders selling.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Oragenics Inc Stock Forecast
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
Oragenics Inc Stock Price History
Is Oragenics Inc Stock Undervalued? The current Oragenics Inc [ OGEN] share price is $0.42. The Score for OGEN is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Stock Predictions
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OGEN is experiencing slight buying pressure.
Stock Price Forecast
Is Oragenics Inc stock public? Yes, Oragenics Inc is a publicly traded company.
Analyst Recommendations
The 7 analysts offering 12-month price forecasts for Organon & Co have a median target of 40.00, with a high estimate of 44.00 and a low estimate of 37.00. The median estimate represents a +11.20% increase from the last price of 35.97.
